Abstract
Persistent inflammation-driven oxidative stress impairs tissue remodeling in chronic wounds, a process closely linked to macrophage dysfunction. Here, we report a novel single-atom ruthenium nanozyme (RuSAC@PS) with Ru–N4 coordination and phosphatidylserine targeting for macrophage delivery. This nanozyme achieves dual exogenous and endogenous ROS scavenging. It eliminates exogenous ROS through intrinsic SOD/CAT-like activities, with ultralow metal loading (~0.3 wt%) ensuring high catalytic efficiency and biocompatibility. Crucially, we first demonstrate that this artificial catalyst restores SHPK-mediated metabolic homeostasis to suppress endogenous ROS overproduction intracellularly. This dual action breaks the ROS–NF-κB feedback loop, reprograms macrophage metabolism from glycolysis to oxidative phosphorylation, and promotes M2-type polarization. In diabetic wound models, RuSAC@PS accelerates healing, enhances neovascularization, and improves collagen remodeling to reduce scarring. This work establishes a new paradigm for targeted single-atom nanozymes that actively modulate macrophage metabolism and polarization, offering a highly translatable catalytic strategy for chronic inflammatory disorders.
| Original language | English |
|---|---|
| Article number | 183575 |
| Journal | Chemical Engineering Journal |
| Volume | 549 |
| DOIs | |
| Publication status | Published - 1 Dec 2026 |
| Externally published | Yes |
Keywords
- Diabetic wound healing
- M2 polarization
- Macrophage targeting
- Metabolic reprogramming
- ROS scavenging
- Single-atom nanozymes
Fingerprint
Dive into the research topics of 'Macrophage-targeted single-atom catalytic therapeutics recover SHPK-mediated metabolic homeostasis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver